Giuseppe Campiani

26PUBLICATIONS
84CO-AUTHORS
Haematological tumoursCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)Molecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 04, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4.

|Jun 29, 2026
Integrated structure-based and fragment-guided design of isonicotinic acid derivatives as potential KDM4A inhibitors: an in silico study.

|Feb 23, 2026
Quinazolinone-Based PqsR Modulators Suppress Quorum-Sensing-Driven Virulence in Pseudomonas aeruginosa.

Valeria Tudino, Marta Mellini, Leonardo Milioni

|Feb 04, 2026
Oxyprenyl-chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability prediction.

Ludovica Marotta, Francesca Maria Pia Rita Giammarino, Brondon Brandly Senenou Tambou

|Jan 05, 2026
Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo.

Gabriele Carullo, Federica Falbo, Valeria Tudino

|Aug 12, 2025
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors.

Gabriele Carullo, Ilaria Piano, Giulia Salamone

Pageof 5

Frequent Collaborators

22 joint publications

Sandra Gemma

21 joint publications

Stefania Butini

21 joint publications

Gabriele Carullo

14 joint publications

Simone Brogi